153 related articles for article (PubMed ID: 37530646)
1. Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4-mediated ferroptosis.
Qiu ML; Yan W; Liu MM
Kaohsiung J Med Sci; 2023 Oct; 39(10):989-1001. PubMed ID: 37530646
[TBL] [Abstract][Full Text] [Related]
2. WTAP-mediated m6A modification of KLF6 aggravates hypoxia/reoxygenation-induced human cardiomyocyte injury.
Fang M; Li T; Wu Z
Shock; 2024 Apr; ():. PubMed ID: 38662610
[TBL] [Abstract][Full Text] [Related]
3. Chondroprotective effects of bone marrow mesenchymal stem cell-derived exosomes in osteoarthritis.
Cheng S; Xu X; Wang R; Chen W; Qin K; Yan J
J Bioenerg Biomembr; 2024 Feb; 56(1):31-44. PubMed ID: 38012335
[TBL] [Abstract][Full Text] [Related]
4. EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
Yu Q; Zhang N; Gan X; Chen L; Wang R; Liang R; Jian J
Phytomedicine; 2023 Oct; 119():154999. PubMed ID: 37597361
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
[TBL] [Abstract][Full Text] [Related]
6. YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
Qiu M; Yan W; Liu M
Can J Cardiol; 2023 Nov; 39(11):1712-1727. PubMed ID: 37541340
[TBL] [Abstract][Full Text] [Related]
7. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia/reoxygenation-induced cardiomyocytes.
Zhao C; Li J
J Cardiothorac Surg; 2024 Apr; 19(1):265. PubMed ID: 38664788
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte.
Zheng Y; Wang L; Zhao Y; Gong H; Qi Y; Qi L
Int J Cardiol; 2024 Mar; 399():131688. PubMed ID: 38158136
[TBL] [Abstract][Full Text] [Related]
9. LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury
Sun W; Wu X; Yu P; Zhang Q; Shen L; Chen J; Tong H; Fan M; Shi H; Chen X
Front Cell Dev Biol; 2022; 10():672391. PubMed ID: 35186915
[TBL] [Abstract][Full Text] [Related]
10. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway.
Han Y; Yuan H; Li F; Yuan Y; Zheng X; Zhang X; Sun J
BMC Complement Med Ther; 2023 Dec; 23(1):459. PubMed ID: 38102654
[TBL] [Abstract][Full Text] [Related]
11. HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis.
Zhang F; Li Z; Gao P; Zou J; Cui Y; Qian Y; Gu R; Xu W; Hu J
Front Pharmacol; 2022; 13():1024292. PubMed ID: 36483736
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis.
Lei D; Li B; Isa Z; Ma X; Zhang B
Tissue Cell; 2022 Dec; 79():101956. PubMed ID: 36272206
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
Li W; Li W; Leng Y; Xiong Y; Xia Z
DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
[TBL] [Abstract][Full Text] [Related]
15. Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis.
Fan Z; Cai L; Wang S; Wang J; Chen B
Front Pharmacol; 2021; 12():628988. PubMed ID: 33935719
[TBL] [Abstract][Full Text] [Related]
16. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
17. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.
Sun Z; Wu J; Bi Q; Wang W
Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017
[TBL] [Abstract][Full Text] [Related]
18. METTL3 promotes trophoblast ferroptosis in preeclampsia by stabilizing the ACSL4 m
Wang Y; Zhang G; Gao Y; Zhang X; Qi H
Exp Cell Res; 2024 Apr; 437(1):113990. PubMed ID: 38462207
[TBL] [Abstract][Full Text] [Related]
19. Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury.
Wu D; Spencer CB; Ortoga L; Zhang H; Miao C
Redox Biol; 2024 Aug; 74():103194. PubMed ID: 38852200
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
